TABLE 2.

Superinfection and persistence of baboon LCV in EBV-transformed PBMCs^a

Treatment	No. of LCLs generated	No. of LCLs positive for EBV EBNA-2/no. of LCLs analyzed	No. of LCLs positive for baboon LCV EBNA-1/no. of LCLs analyzed
Control medium	28	12/12	0/12
Baboon LCV	51	43/43	33/43

^aA total of 10⁷ T-cell-depleted human PBMCs were exposed to control medium or baboon LCV and cultured in a 96-well microtiter plate. Subsequent LCLs were analyzed for the presence of EBV DNA and baboon LCV DNA by amplification for EBV EBNA-2 and LCV EBNA-1 sequences, respectively (Fig. 5).